GASTROINTESTINAL STROMAL TUMOR
Clinical trials for GASTROINTESTINAL STROMAL TUMOR explained in plain language.
Never miss a new study
Get alerted when new GASTROINTESTINAL STROMAL TUMOR trials appear
Sign up with your email to follow new studies for GASTROINTESTINAL STROMAL TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered t cells take on Hard-to-Treat cancers in new trial
Disease control Not yet recruitingThis early-stage study tests a new treatment for people with advanced ovarian cancer or other solid tumors that have come back or not responded to standard therapy. The treatment uses a patient's own immune cells that are genetically modified to better recognize and attack cancer…
Matched conditions: GASTROINTESTINAL STROMAL TUMOR
Phase: PHASE1, PHASE2 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 22, 2026 12:04 UTC
-
New hope for stubborn GIST: experimental drug DCC-2618 enters safety testing
Disease control Not yet recruitingThis early-stage study tests the safety of an experimental drug called DCC-2618 in 10 people with advanced gastrointestinal stromal tumor (GIST) that has not responded to or cannot tolerate at least three prior treatments. The main goal is to see what side effects occur. This is …
Matched conditions: GASTROINTESTINAL STROMAL TUMOR
Phase: PHASE1 • Sponsor: Ono Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC